Home › Funds › Arrowstreet Capital › EXEL
Arrowstreet Capital position in EXEL
EXELIXIS INC · Health Care
Latest position (Q2 2026)4.37M sh
Reported value held$237.55M
Portfolio Weight0.11%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 252.44K | $5.34M | New |
| Q4 2021 | 732.86K | $13.40M | Add |
| Q2 2022 | 942.75K | $19.63M | New |
| Q3 2022 | 151.61K | $2.38M | Reduce |
| Q4 2022 | 304.59K | $4.89K | Add |
| Q4 2023 | 79.46K | $1.91K | New |
| Q1 2024 | 421.47K | $10.00K | Add |
| Q2 2024 | 1.20M | $26.91K | Add |
| Q3 2024 | 1.55M | $40.12M | Add |
| Q4 2024 | 3.16M | $105.21M | Add |
| Q1 2025 | 3.68M | $135.94M | Add |
| Q2 2025 | 5.26M | $231.95M | Add |
| Q3 2025 | 5.27M | $217.57M | Hold |
| Q4 2025 | 5.28M | $231.30M | Hold |
| Q1 2026 | 4.83M | $207.36M | Reduce |
| Q2 2026 | 4.37M | $237.55M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EXEL
- BlackRock Inc 29.08M sh · $1.58B · Q2 2026
- Vanguard Group 25.49M sh · $1.12B · Q4 2025
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- Renaissance Technologies 13.43M sh · $730.62M · Q2 2026
- AQR Capital Management 11.02M sh · $598.60M · Q2 2026
- Geode Capital Management 7.65M sh · $416.32M · Q2 2026
- D. E. Shaw & Co 5.55M sh · $302.07M · Q2 2026
- Morgan Stanley 4.52M sh · $245.92M · Q2 2026
- Invesco Ltd 4.50M sh · $244.61M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- UBS Group AG 3.17M sh · $172.36M · Q2 2026